Peregrine Investment Management Inc Beam Therapeutics Inc. Transaction History
Peregrine Investment Management Inc
- $204 Billion
- Q3 2025
A detailed history of Peregrine Investment Management Inc transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Peregrine Investment Management Inc holds 267,930 shares of BEAM stock, worth $6.02 Million. This represents 3.19% of its overall portfolio holdings.
Number of Shares
267,930
Previous 264,260
1.39%
Holding current value
$6.02 Million
Previous $4.5 Billion
44.66%
% of portfolio
3.19%
Previous 2.87%
Shares
4 transactions
Others Institutions Holding BEAM
# of Institutions
249Shares Held
98.8MCall Options Held
636KPut Options Held
1.96M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11MShares$248 Million1.88% of portfolio
-
Farallon Capital Management LLC San Francisco, CA10MShares$225 Million0.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.25MShares$208 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$172 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.4.83MShares$109 Million0.07% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.58B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...